Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 30
- Next page
Title | Authors | Year | Journal | Link to Article | Intended Audience Sort descending | Purpose |
---|---|---|---|---|---|---|
Importance du fer chez les donneurs de sang total : la perspective canadienne | Pambrun C, Goldman M | 2018 | Blood.ca website | View Importance du fer chez les donneurs de sang total : la perspective canadienne | Health care providers | Other |
Neutropenia and monocytopenia in recurrent anaphylactoid reactions after red blood cell transfusions in a woman with immunoglobulin A (IgA) deficiency and anti-IgA | Warkentin TE, Morin P-A, Heddle NM | 2018 | Transfusion | View Neutropenia and monocytopenia in recurrent anaphylactoid reactions after red blood cell transfusions in a woman with immunoglobulin A (IgA) deficiency and anti-IgA | Health care providers | Clinical research |
Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: ?possible cohort effect following the 2009 influenza pandemic | Skowronski DM, Leir S, De Serres G, Murti M, Dickinson JA, Winter A-L, Olsha R, Croxen MA, Drews SJ, Charest H, Martineau C, Sabaiduc S, Bastien N, Li Y, Petric M, Jassem A, Krajden M, Gubbay JB | 2019 | Euro Surveill | View Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: ?possible cohort effect following the 2009 influenza pandemic | Health care providers | Clinical research |
Système Kell : l’anticorps anti-Jsa | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Système Kell : l’anticorps anti-Jsa | Health care providers | Benchmarking and standard setting |
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 | Cuker A, Tseng EK, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K, Davila J, DeSancho MT, Diuguid D, Griffin DO, Kahn SR, Klok FA, Lee AI, Neumann I, Pai A, Pai M, Righini M, Sanfilippo KM, Siegal D, Skara M, Touri K, E AA, Bou Akl I, Boulos M, Brignardello-Petersen R, Charide R, Chan M, Dearness K, Darzi AJ, Kolb P, Colunga-Lozano LE, Mansour R, Morgano GP, Morsi RZ, Noori A, Piggott T, Qiu Y, Roldan Y, Schünemann F, Stevens A, Solo K, Ventresca M, Wiercioch W, Mustafa RA, Schünemann HJ | 2021 | Blood Adv | View American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 | Health care providers | Benchmarking and standard setting |
Circulaire d'information utilisation de composants sanguins humains: Culot globulaire partiellement déleucocyté (PD) | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
Exploring the frontiers of IVIG-associated hemolysis | Pendergrast J, Branch D | 2020 | Blood.ca website | View Exploring the frontiers of IVIG-associated hemolysis | Health care providers | Benchmarking and standard setting |
A user guide to the American Society of Hematology clinical practice guidelines | Izcovich A, Cuker A, Kunkle R, Neumann I, Panepinto J, Pai M, Seftel M, Cheung MC, Lottenberg R, Byrne M, Plovnick R, Terrell D, Holter-Chakrabarty JL, Djulbegovic B, Hicks LK, Wiercioch W, Nieuwlaat R, Schünemann HJ | 2020 | Blood Adv | View A user guide to the American Society of Hematology clinical practice guidelines | Health care providers | Benchmarking and standard setting |
Acute thrombocytopenia suggesting thrombotic microangiopathy | Venier LM, Patriquin CJ, Warkentin TE | 2022 | Am J Hematol | View Acute thrombocytopenia suggesting thrombotic microangiopathy | Health care providers | Clinical research |
Recognizing, managing and reporting vaccine-induced immune thrombotic thrombocytopenia | Sholzberg M, Arnold DM, Laupacis A | 2021 | CMAJ | View Recognizing, managing and reporting vaccine-induced immune thrombotic thrombocytopenia | Health care providers | Clinical research |
International Forum on the Management of Major Haemorrhage: Summary | Green L, Stanworth S, McQuilten Z, Lin V, Tucker H, Jackson B, Badawi M, Hindawi S, Chaurasia R, Patidar G, Pandey HC, Fasola F, Miyata S, Matsumoto M, Matsushita T, Rahimi-Levene N, Peer V, Pavenski K, Callum J, Thompson T, Murphy M, Staves J, Maegele M, Abeyakoon C, Rushford K, Wood E, Nuñez MA, Mellado S, Saa E, Triyono T, Pratomo B, Apelseth TO, Dunbar N | 2022 | Vox Sang | View International Forum on the Management of Major Haemorrhage: Summary | Health care providers | Benchmarking and standard setting |
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score | COVIDSurg Collaborative | 2021 | Br J Surg | View Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score | Health care providers | Benchmarking and standard setting |
The importance of iron for whole blood donors: a Canadian perspective | Khandelwal A, Pambrun C, Goldman M | 2023 | Blood.ca website | View The importance of iron for whole blood donors: a Canadian perspective | Health care providers | Benchmarking and standard setting |
Chapitre 14. Aphérèse thérapeutique | Oliver M, Patriquin C | 2023 | Guide de la pratique transfusionnelle | View Chapitre 14. Aphérèse thérapeutique | Health care providers | Benchmarking and standard setting |
Circulaire d'information utilisation de composants sanguins humains: Plaquettes | Stewart T | 2022 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Plaquettes | Health care providers | Benchmarking and standard setting |
A brief survey of clinicians' perceptions of parent preferences for involvement in obstetrical and perinatal management decisions in haemophilia | Lucier KJ, Movilla RV, Parvizian MK, Siddiqui R, Gabriele EH, Bourque M, MacIsaac J, Moorehead PC, Chan AK, Heddle NM, Lane SJ | 2018 | Haemophilia | View A brief survey of clinicians' perceptions of parent preferences for involvement in obstetrical and perinatal management decisions in haemophilia | Health care providers | Clinical research |
A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia | Arnold DM, Kukaswadia S, Nazi I, Esmail A, Dewar L, Smith JW, Warkentin TE, Kelton JG | 2013 | J Thromb Haemost | View A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia | Health care providers | Clinical research |
Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value–Tailored Approach | Sheppard D, Tay J, Palmer D, Xenocostas A, Doulaverakis C, Huebsch L, McDiarmid S, Tinmouth A, Mallick R, Martin L, Birch P, Hamelin L, Allan D, Bredeson C | 2015 | Biol Blood Marrow Transplant | View Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value–Tailored Approach | Health care providers | New or improved product or process |
Low pertussis toxin antibody levels in two regional cohorts of Canadian pregnant women | Bigham M, Konrad S, Van Buynder P, Van Buynder J, Isaac-Renton J, ElSherif M, Halperin SA | 2014 | Vaccine | View Low pertussis toxin antibody levels in two regional cohorts of Canadian pregnant women | Health care providers | Clinical research |
Plasma and Plasma Protein Product Transfusion: A Canadian Blood Services Centre for Innovation Symposium | Zeller MP, Al-Habsi KS, Golder M, Walsh GM, Sheffield WP | 2015 | Transfus Med Rev | View Plasma and Plasma Protein Product Transfusion: A Canadian Blood Services Centre for Innovation Symposium | Health care providers | Other |
Understanding stakeholder important outcomes and perceptions of equity, acceptability and feasibility of a care model for haemophilia management in the US: a qualitative study | Lane SJ, Sholapur NS, Yeung CH, Iorio A, Heddle NM, Sholzberg M, Pai M | 2016 | Haemophilia | View Understanding stakeholder important outcomes and perceptions of equity, acceptability and feasibility of a care model for haemophilia management in the US: a qualitative study | Health care providers | Other |
Warm-reactive (immunoglobulin G) autoantibodies and laboratory testing best practices: review of the literature and survey of current practice | Ziman A, Cohn C, Carey PM, Dunbar NM, Fung MK, Greinacher A, Stanworth S, Heddle NM, Delaney M | 2017 | Transfusion | View Warm-reactive (immunoglobulin G) autoantibodies and laboratory testing best practices: review of the literature and survey of current practice | Health care providers | New or improved product or process |
Addressing the identity crisis in healthcare: positive patient identification technology reduces wrong patient events | Callum J, Etchells E, Shojania K | 2019 | Transfusion | View Addressing the identity crisis in healthcare: positive patient identification technology reduces wrong patient events | Health care providers | Clinical research |
Investigations for fetal and neonatal alloimmune thrombocytopenia: communication from the SSC of the ISTH | Petermann R, Bakchoul T, Curtis BR, Mullier F, Miyata S, Arnold DM, Subcommittee on platelet immunology | 2018 | J Thromb Haemost | View Investigations for fetal and neonatal alloimmune thrombocytopenia: communication from the SSC of the ISTH | Health care providers | Benchmarking and standard setting |
Impact of Adopting Population Pharmacokinetics for Tailoring Prophylaxis in Haemophilia A Patients: A Historically Controlled Observational Study | Stemberger M, Kallenbach F, Schmit E, McEneny-King A, Germini F, Yeung CHT, Edginton AN, von Mackensen S, Kurnik K, Iorio A | 2019 | Thromb Haemost | View Impact of Adopting Population Pharmacokinetics for Tailoring Prophylaxis in Haemophilia A Patients: A Historically Controlled Observational Study | Health care providers | Clinical research |
Transfusion de plaquettes, l'allo-immunisation et la prise en charge de l'état réfractaire aux plaquettes | Zeller M, Petraszko T | 2018 | Guide de la pratique transfusionnelle | View Transfusion de plaquettes, l'allo-immunisation et la prise en charge de l'état réfractaire aux plaquettes | Health care providers | Other |
Management of major bleeds in patients with immune thrombocytopenia | Mithoowani S, Cervi A, Shah N, Ejaz R, Sirotich E, Barty R, Li N, Nazy I, Arnold DM | 2020 | J Thromb Haemost | View Management of major bleeds in patients with immune thrombocytopenia | Health care providers | Clinical research |
A regional massive hemorrhage protocol developed through a modified Delphi technique | Callum JL, Yeh CH, Petrosoniak A, McVey MJ, Cope S, Thompson T, Chin V, Karkouti K, Nathens AB, Murto K, Beno S, Pendergrast J, McDonald A, MacDonald R, Adhikari NKJ, Alam A, Arnold D, Barratt L, Beckett A, Brenneman S, Chaudhry HR, Collins A, Harvey M, Lampron J, Margarido C, McFarlan A, Nascimento B, Owens W, Pai M, Rizoli S, Ruijs T, Skeate R, Skelton T, Sholzberg M, Syer K, Viveiros JL, Theriault J, Tinmouth A, Van Heest R, White S, Zeller M, Pavenski K | 2019 | CMAJ Open | View A regional massive hemorrhage protocol developed through a modified Delphi technique | Health care providers | Clinical research |
Transfusion-related Acute Lung Injury in the Perioperative Patient | McVey MJ, Kapur R, Cserti-Gazdewich C, Semple JW, Karkouti K, Kuebler WM | 2019 | Anesthesiology | View Transfusion-related Acute Lung Injury in the Perioperative Patient | Health care providers | Clinical research |
Blood Administration | O'Reilly C | 2020 | Clinical Guide to Transfusion | View Blood Administration | Health care providers | Benchmarking and standard setting |
Haemolytic diseases | Armstrong B, Smart E, Reviewer for Second Edition: Bodnar M and Clarke G | 2020 | ISBT Science Series | View Haemolytic diseases | Health care providers | Benchmarking and standard setting |
Management of major bleeds in patients with immune thrombocytopenia | Mithoowani S, Cervi A, Shah N, Ejaz R, Sirotich E, Barty R, Li N, Nazy I, Arnold DM | 2020 | J Thromb Haemost | View Management of major bleeds in patients with immune thrombocytopenia | Health care providers | Clinical research |
Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination | Gabarin N, Patterson S, Pai M, Afzaal T, Nazy I, Sheppard JI, Arnold DM, Warkentin TE | 2021 | Thromb Haemost | View Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination | Health care providers | Clinical research |
Reconsidering sickle cell trait testing of red blood cell units allocated to children with sickle cell disease | Hajjaj OI, Cserti-Gazdewich C, Dumevska L, Hanna M, Lau W, Lieberman L | 2023 | Transfusion | View Reconsidering sickle cell trait testing of red blood cell units allocated to children with sickle cell disease | Health care providers | Clinical research |
How do I provide rare red cells to patients? | Laureano M, Clarke G, Yan MTS | 2023 | Transfusion | View How do I provide rare red cells to patients? | Health care providers | Benchmarking and standard setting |
Chapitre 5. Concentrés pour les troubles de l’hémostase et l’angiœdème héréditaire | Poon MC, Goodyear D, Rydz N, Lee A | 2022 | Guide de la pratique transfusionnelle | View Chapitre 5. Concentrés pour les troubles de l’hémostase et l’angiœdème héréditaire | Health care providers | Benchmarking and standard setting |
Risk of serious gastrointestinal bleeding in living kidney donors | Thomas SM, Lam NN, Huang A, Nash DM, Prasad GV, Knoll GA, Koval JJ, Lentine KL, Kim SJ, Alam A, Lok CE, Treleaven DJ, Garg AX | 2014 | Clin Transplant | View Risk of serious gastrointestinal bleeding in living kidney donors | Health care providers | Clinical research |
Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement | Iorio A, Iserman E, Blanchette V, Dolan G, Escuriola Ettingshausen C, Hermans C, Negrier C, Oldenburg J, Reininger A, Rodriguez-Merchan C, Spannagl M, Valentino LA, Young G, Steinitz-Trost KN, Gringeri A | 2017 | Haemophilia | View Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement | Health care providers | Clinical research |
Transfusion premedication practices among pediatric health care practitioners in Canada: results of a national survey | Solh Z, Chan AK, Heddle NM | 2016 | Transfusion | View Transfusion premedication practices among pediatric health care practitioners in Canada: results of a national survey | Health care providers | Clinical research |
Utilisation des produits sanguins CMV négatifs | Ryan J | 2017 | Blood.ca website | View Utilisation des produits sanguins CMV négatifs | Health care providers | Benchmarking and standard setting |
Chloride and other electrolyte concentrations in commonly available 5% albumin products | Lai AT, Zeller MP, Millen T, Kavsak P, Szczeklik W, Elahie A, Alhazzani W, D'Aragon F, Jaeschke R, Lamontagne F, Karachi T, Cook D, Meade M, Rochwerg B, on behalf of The Canadian Critical Care Trials Group | 2018 | Crit Care Med | View Chloride and other electrolyte concentrations in commonly available 5% albumin products | Health care providers | Clinical research |
What is the role of rapid molecular testing for seniors and other at-risk adults with respiratory syncytial virus infections? | Drews SJ, Branche AR, Falsey AR, Lee N | 2019 | J Clin Virol | View What is the role of rapid molecular testing for seniors and other at-risk adults with respiratory syncytial virus infections? | Health care providers | Clinical research |
Épreuves prétransfusionnelles | Duncan J | 2020 | Guide de la pratique transfusionnelle | View Épreuves prétransfusionnelles | Health care providers | Benchmarking and standard setting |
Improved access to better HLA-matched hematopoietic cells for allogeneic transplant: analysis of donors and cord blood units selected for Canadian patients in 2018 | Greco-Stewart V, Elmoazzen H, Morris G, Guo Y, Langdon C, Mercer D, Dibdin N, Allan DS | 2020 | Transfusion | View Improved access to better HLA-matched hematopoietic cells for allogeneic transplant: analysis of donors and cord blood units selected for Canadian patients in 2018 | Health care providers | Clinical research |
Transfusion-transmitted and community-acquired cytomegalovirus infection in seronegative solid organ transplant recipients receiving seronegative donor organs | Mabilangan C, Burton C, Nahirniak S, O'Brien S, Preiksaitis J | 2020 | Am J Transplant | View Transfusion-transmitted and community-acquired cytomegalovirus infection in seronegative solid organ transplant recipients receiving seronegative donor organs | Health care providers | Clinical research |
Circular of information for the use of human blood components: Pathogen Reduced Platelet Concentrates | Stewart T | 2022 | Blood.ca website | View Circular of information for the use of human blood components: Pathogen Reduced Platelet Concentrates | Health care providers | Benchmarking and standard setting |
Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: Communication from the ISTH SSC Subcommittee on Platelet Immunology | Nazy I, Sachs UJ, Arnold DM, McKenzie SE, Choi P, Althaus K, Ahlen MT, Sharma R, Grace RF, Bakchoul T | 2021 | J Thromb Haemost | View Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: Communication from the ISTH SSC Subcommittee on Platelet Immunology | Health care providers | Benchmarking and standard setting |
Chapitre 2: Les composants sanguins | Gupta A, Bigham M | 2021 | Guide de la pratique transfusionnelle | View Chapitre 2: Les composants sanguins | Health care providers | Benchmarking and standard setting |
Epidemiology of Hospitalized Patients with Babesiosis, United States, 2010-2016 | Bloch EM, Day JR, Krause PJ, Kjemtrup A, O'Brien SF, Tobian AAR, Goel R | 2022 | Emerg Infect Dis | View Epidemiology of Hospitalized Patients with Babesiosis, United States, 2010-2016 | Health care providers | Clinical research |
Cost-effectiveness of Fibrinogen Concentrate vs Cryoprecipitate for Treating Acquired Hypofibrinogenemia in Bleeding Adult Cardiac Surgical Patients | Abrahamyan L, Tomlinson G, Callum J, Carcone S, Grewal D, Bartoszko J, Krahn M, Karkouti K | 2023 | JAMA Surg | View Cost-effectiveness of Fibrinogen Concentrate vs Cryoprecipitate for Treating Acquired Hypofibrinogenemia in Bleeding Adult Cardiac Surgical Patients | Health care providers | Clinical research |